Medtronic Sprint Fidelis defibrillator leads Bard Composix Kugel Hernia Mesh Patch

With horrific stories of consumers suffering due to defective medical devices, some federal lawmakers are working to overturn the Supreme Court’s fateful Riegel v. Medtronic decision which gave FDA-approved medical devices immunity from state court lawsuits. The results of this court decision have been documented in tragic detail in today’s NY Times.
The decision is even more problematic and injurious for consumers given the FDA’s track record, especially recently, concerning consumer safety. The FDA has been particularly inept at keeping harmful drugs and dangerously defective medical devices off the market and out of the reach of consumers. We only have to look at recent examples such as Vioxx, Medtronic’s Sprint Fidelis defibrillator leads, Bard Composix Kugel Mesh Patch, to name a few.
Hopefully, lawmakers will craft legislation for President Obama’s signature that will ensure a return to consumer confidence and consumer safety. Reversing the effects of Riegel v. Medtronic would go along way to do just that.